Trial
NCT01293539
Intra-arterial Chemotherapy for the Treatment of Intraocular Retinoblastoma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
—
Condition
Retinoblastoma
Intervention
Melphalan hydrochloride
Why stopped
IAC is now recognized as part of standard of care treatment options in the US.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-11-27